ES495354A0 - Un procedimiento para la preparacion de un compuesto de 1,1-dioxido de penam - Google Patents

Un procedimiento para la preparacion de un compuesto de 1,1-dioxido de penam

Info

Publication number
ES495354A0
ES495354A0 ES495354A ES495354A ES495354A0 ES 495354 A0 ES495354 A0 ES 495354A0 ES 495354 A ES495354 A ES 495354A ES 495354 A ES495354 A ES 495354A ES 495354 A0 ES495354 A0 ES 495354A0
Authority
ES
Spain
Prior art keywords
penam
procedure
preparation
dioxide compound
dioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES495354A
Other languages
English (en)
Other versions
ES8106528A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES495354A0 publication Critical patent/ES495354A0/es
Publication of ES8106528A1 publication Critical patent/ES8106528A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES495354A 1979-09-26 1980-09-25 Un procedimiento para la preparacion de un compuesto de 1,1-dioxido de penam Expired ES8106528A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/079,127 US4256733A (en) 1979-09-26 1979-09-26 Acetoxymethyl penam compounds as β-lactamase inhibitors

Publications (2)

Publication Number Publication Date
ES495354A0 true ES495354A0 (es) 1981-08-16
ES8106528A1 ES8106528A1 (es) 1981-08-16

Family

ID=22148609

Family Applications (1)

Application Number Title Priority Date Filing Date
ES495354A Expired ES8106528A1 (es) 1979-09-26 1980-09-25 Un procedimiento para la preparacion de un compuesto de 1,1-dioxido de penam

Country Status (36)

Country Link
US (1) US4256733A (es)
JP (1) JPS6016958B2 (es)
KR (1) KR840000796B1 (es)
AR (1) AR224547A1 (es)
AT (1) AT366384B (es)
AU (1) AU517074B2 (es)
BE (1) BE885389A (es)
CA (1) CA1150242A (es)
CH (1) CH645646A5 (es)
CS (1) CS212284B2 (es)
DD (1) DD153123A5 (es)
DE (1) DE3035995C2 (es)
DK (1) DK404980A (es)
EG (1) EG14888A (es)
ES (1) ES8106528A1 (es)
FI (2) FI67552C (es)
FR (1) FR2465736A1 (es)
GB (2) GB2059420B (es)
GR (1) GR70065B (es)
HU (1) HU183212B (es)
IE (2) IE50507B1 (es)
IL (1) IL61117A (es)
IN (1) IN154557B (es)
IT (1) IT1132754B (es)
LU (1) LU82795A1 (es)
MX (1) MX6580E (es)
NL (1) NL185923C (es)
NO (2) NO160370C (es)
NZ (1) NZ195058A (es)
PH (1) PH15697A (es)
PL (1) PL126949B1 (es)
PT (1) PT71837B (es)
SE (2) SE449865B (es)
SU (1) SU959628A3 (es)
YU (1) YU41733B (es)
ZA (1) ZA805132B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364957A (en) * 1979-09-26 1982-12-21 Pfizer Inc. Bis-esters of alkanediols as antibacterial agents
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
US4361513A (en) * 1980-12-11 1982-11-30 Pfizer Inc. Esters of penicillanic acid sulfone
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4558042A (en) * 1981-05-06 1985-12-10 Farmitalia Carlo Erba S.P.A. β-Lactam-containing antibacterial agents and β-lactamase inhibitors
ZA826687B (en) * 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
JPS58185589A (ja) * 1982-04-23 1983-10-29 Taiho Yakuhin Kogyo Kk ペニシリン誘導体
JPS62198687A (ja) * 1986-02-27 1987-09-02 Taiho Yakuhin Kogyo Kk 2β−置換チオメチルペニシリン誘導体
US4861768A (en) * 1986-02-27 1989-08-29 Taiho Pharmaceutical Company, Limited 2 β-substituted thiomethylpenicillin derivatives and their preparation and use
SK63894A3 (en) * 1991-12-19 1995-03-08 Novo Nordisk As Method of preparation of beta-lactam antibiotic
CN115385934A (zh) * 2022-10-26 2022-11-25 北京纳百生物科技有限公司 一种舒巴坦半抗原及其合成方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN149747B (es) * 1977-06-07 1982-04-03 Pfizer

Also Published As

Publication number Publication date
GB2125037B (en) 1984-08-01
LU82795A1 (fr) 1981-04-17
NO160299C (no) 1989-04-05
NL185923C (nl) 1990-08-16
YU41733B (en) 1987-12-31
KR830003494A (ko) 1983-06-20
IE801095L (en) 1981-01-09
ZA805132B (en) 1981-12-30
SE8005714L (sv) 1981-03-27
IT8024920A0 (it) 1980-09-25
NL185923B (nl) 1990-03-16
FI67854B (fi) 1985-02-28
NO831082L (no) 1981-03-27
GB8319784D0 (en) 1983-08-24
IL61117A0 (en) 1980-11-30
NO160370C (no) 1989-04-12
AU6271380A (en) 1981-04-09
DE3035995C2 (de) 1985-01-10
PL226868A1 (es) 1981-10-16
IN154557B (es) 1984-11-10
AR224547A1 (es) 1981-12-15
GR70065B (es) 1982-07-26
FR2465736B1 (es) 1982-04-30
FR2465736A1 (fr) 1981-03-27
IT1132754B (it) 1986-07-02
IE50507B1 (en) 1986-04-30
CA1150242A (en) 1983-07-19
HU183212B (en) 1984-04-28
NL8005344A (nl) 1981-03-30
BE885389A (fr) 1981-03-25
CH645646A5 (fr) 1984-10-15
IE801998L (en) 1981-03-26
NZ195058A (en) 1982-12-07
PT71837A (en) 1980-10-01
GB2059420A (en) 1981-04-23
JPS6016958B2 (ja) 1985-04-30
DE3035995A1 (de) 1981-04-02
KR840000796B1 (ko) 1984-06-12
SE8500965D0 (sv) 1985-02-27
IL61117A (en) 1983-10-31
EG14888A (en) 1985-06-30
AT366384B (de) 1982-04-13
GB2125037A (en) 1984-02-29
AU517074B2 (en) 1981-07-09
NO802836L (no) 1981-03-27
FI67552C (fi) 1985-04-10
GB2059420B (en) 1984-03-14
PL126949B1 (en) 1983-09-30
SU959628A3 (ru) 1982-09-15
CS212284B2 (en) 1982-03-26
FI840367A0 (fi) 1984-01-30
US4256733A (en) 1981-03-17
IE50506B1 (en) 1986-04-30
YU244980A (en) 1983-02-28
ES8106528A1 (es) 1981-08-16
FI67552B (fi) 1984-12-31
NO160299B (no) 1988-12-27
FI803028A (fi) 1981-03-27
FI67854C (fi) 1985-06-10
SE449865B (sv) 1987-05-25
JPS5657788A (en) 1981-05-20
MX6580E (es) 1985-07-24
SE461528B (sv) 1990-02-26
NO160370B (no) 1989-01-02
PH15697A (en) 1983-03-14
FI840367A (fi) 1984-01-30
ATA474680A (de) 1981-08-15
DK404980A (da) 1981-03-27
PT71837B (en) 1981-07-09
DD153123A5 (de) 1981-12-23

Similar Documents

Publication Publication Date Title
ES487381A0 (es) Un procedimiento para la preparacion de un compuesto de guanidinotiazol
ES496442A0 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina
ES506661A0 (es) Un procedimiento para la preparacion de nuevos derivados de la sacarosa industrialmente utiles.
ES514994A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES487843A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES488886A0 (es) Un procedimiento para la preparacion de derivados acidos penemcarboxilicos.
ES510307A0 (es) Un procedimiento para la preparacion de un compuesto de cefalosporina.
ES495586A0 (es) Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona.
ES495163A0 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES490722A0 (es) Un procedimiento para la preparacion de nuevos derivados de piridazina.
ES497366A0 (es) Un procedimiento para la preparacion de nuevos compuestos de mercaptoorganosiloxano.
ES493846A0 (es) Un procedimiento para la preparacion de nuevos compuestos oligolipidos.
ES485072A0 (es) Un procedimiento para la preparacion de compuestos de 4-tia-zolidinona.
ES495354A0 (es) Un procedimiento para la preparacion de un compuesto de 1,1-dioxido de penam
ES499241A0 (es) Un procedimiento para la preparacion de un compuesto de ce- falosporina
ES521277A0 (es) Un procedimiento para la preparacion de derivados de penem sustituidos.
ES496485A0 (es) Un procedimiento para la preparacion de nuevos 1,2,4-triazo-les
ES510036A0 (es) "un procedimiento para la preparacion de derivados de tiazolidina".
ES512079A0 (es) "un procedimiento para la preparacion de nuevos acilderivados de cefalosporina".
MX6832E (es) Procedimiento mejorado para la preparacion de un compuesto de s-triazina
ES495589A0 (es) Un procedimiento para la preparacion de derivados de imida- lol.
ES494130A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoxocina.
ES497342A0 (es) Un procedimiento para la preparacion de un compuesto de biu-ret 1,1,3,5-sustituido
ES495137A0 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
ES508152A0 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970505